江湖电竞外围
€ 46.42
Previous Close |
---|
€46.39 |
Overview
QIA Overview
Key Data
- Open €46.43
- Day Range 45.96 - 46.76
- 52 Week Range 37.95 - 51.56
- Market Cap €10.51B
- Shares Outstanding 227.07M
- Public Float 226.2M
- Beta 0.32
- Rev. per Employee €333.07K
- P/E Ratio 23.56
- EPS €1.97
- Yield N/A
- Dividend N/A
- Ex-Dividend Date N/A
- Short Interest N/A
- % of Float Shorted N/A
- Average Volume 498.97K
Performance
5 Day |
|
1 Month |
|
3 Month |
|
YTD |
|
1 Year |
|
Analyst Ratings
Qiagen N.V.
QIAGEN NV is a provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The firm assay technologies make these biomolecules visible and ready for analysis. Its bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. The firm automation solutions tie these together in seamless and cost-effective workflows. QIAGEN provides solutions to Molecular Diagnostics (human healthcare) and Life Sciences (academia, pharma R&D, and industrial applications, primarily forensics). The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996, and is headquartered in Venlo, the Netherlands.
Competitors
Name | Chg % | Market Cap |
---|---|---|
Sartorius AG Pfd. |
|
€27.96B |
Stratec SE |
|
€1.03B |
Lumibird S.A. |
|
€435.84M |